Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study

Abstract Visceral adiposity is a major risk factor of cardiometabolic diseases. Visceral adipose tissue (VAT) is usually measured with expensive imaging techniques which present financial and practical challenges to population-based studies. We assessed whether cardiometabolic conditions were associ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Ruiz-Castell, Hanen Samouda, Valery Bocquet, Guy Fagherazzi, Saverio Stranges, Laetitia Huiart
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dd9a5c96633f4b26b903fea847d2eccd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dd9a5c96633f4b26b903fea847d2eccd
record_format dspace
spelling oai:doaj.org-article:dd9a5c96633f4b26b903fea847d2eccd2021-12-02T17:20:11ZEstimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study10.1038/s41598-021-88587-92045-2322https://doaj.org/article/dd9a5c96633f4b26b903fea847d2eccd2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88587-9https://doaj.org/toc/2045-2322Abstract Visceral adiposity is a major risk factor of cardiometabolic diseases. Visceral adipose tissue (VAT) is usually measured with expensive imaging techniques which present financial and practical challenges to population-based studies. We assessed whether cardiometabolic conditions were associated with VAT by using a new and easily measurable anthropometric index previously published and validated. Data (1529 participants) came from the European Health Examination Survey in Luxembourg (2013–2015). Logistic regressions were used to study associations between VAT and cardiometabolic conditions. We observed an increased risk of all conditions associated with VAT. The total adjusted odds ratio (AOR, [95% CI]) for hypertension, prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia for the fourth quartile of VAT compared to the lowest were (10.67 [6.95, 16.39]), (6.14 [4.14, 9.10]), (6.03 [3.97, 9.16]) and (9.18 [5.97, 14.12]). We observed higher odds in women than in men for all outcomes with the exception of hypertension. Future studies should investigate the impact of VAT changes on cardiometabolic health and the use of anthropometrically predicted VAT as an accurate outcome when no biomedical imaging is available.Maria Ruiz-CastellHanen SamoudaValery BocquetGuy FagherazziSaverio StrangesLaetitia HuiartNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maria Ruiz-Castell
Hanen Samouda
Valery Bocquet
Guy Fagherazzi
Saverio Stranges
Laetitia Huiart
Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
description Abstract Visceral adiposity is a major risk factor of cardiometabolic diseases. Visceral adipose tissue (VAT) is usually measured with expensive imaging techniques which present financial and practical challenges to population-based studies. We assessed whether cardiometabolic conditions were associated with VAT by using a new and easily measurable anthropometric index previously published and validated. Data (1529 participants) came from the European Health Examination Survey in Luxembourg (2013–2015). Logistic regressions were used to study associations between VAT and cardiometabolic conditions. We observed an increased risk of all conditions associated with VAT. The total adjusted odds ratio (AOR, [95% CI]) for hypertension, prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia for the fourth quartile of VAT compared to the lowest were (10.67 [6.95, 16.39]), (6.14 [4.14, 9.10]), (6.03 [3.97, 9.16]) and (9.18 [5.97, 14.12]). We observed higher odds in women than in men for all outcomes with the exception of hypertension. Future studies should investigate the impact of VAT changes on cardiometabolic health and the use of anthropometrically predicted VAT as an accurate outcome when no biomedical imaging is available.
format article
author Maria Ruiz-Castell
Hanen Samouda
Valery Bocquet
Guy Fagherazzi
Saverio Stranges
Laetitia Huiart
author_facet Maria Ruiz-Castell
Hanen Samouda
Valery Bocquet
Guy Fagherazzi
Saverio Stranges
Laetitia Huiart
author_sort Maria Ruiz-Castell
title Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
title_short Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
title_full Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
title_fullStr Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
title_full_unstemmed Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
title_sort estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/dd9a5c96633f4b26b903fea847d2eccd
work_keys_str_mv AT mariaruizcastell estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
AT hanensamouda estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
AT valerybocquet estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
AT guyfagherazzi estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
AT saveriostranges estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
AT laetitiahuiart estimatedvisceraladiposityisassociatedwithriskofcardiometabolicconditionsinapopulationbasedstudy
_version_ 1718381054366056448